Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Profound Medical Corp.

Canada

CMS manufacturer 100000646812

Open in the dashboard

General payments

$338,682

1,678 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Profound Medical Corp. reported paying $338,682 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $145,534 945
2024 General $125,200 133
2023 General $26,929 173
2022 General $35,263 340
2021 General $5,542 80
2020 General $214 7

Breakdown

Top recipients General payments · program year 2025
  1. Pejman Ghanouni Diagnostic Radiology · Stanford, CA $11,558 13 payments
  2. Joseph Busch Diagnostic Radiology · Chattanooga, TN $5,227 34 payments
  3. Naveen Kella Urology · San Antonio, TX $4,633 13 payments
  4. Zhamshid Okhunov Urology · Loma Linda, CA $4,633 12 payments
  5. Ram Pathak Urology · Jacksonville, FL $3,852 8 payments
  6. Andrew Krueger Urology · Hendersonville, NC $2,477 8 payments
  7. Sharmila Sewell Physician Assistant · Seattle, WA $2,406 11 payments
  8. Yoon Hong Urology · Phoenix, AZ $2,391 7 payments
  9. Terence Favazza Urology · Live Oak, TX $2,361 4 payments
  10. Preston Sprenkle Urology · New Haven, CT $2,283 5 payments
Products the payments named General payments · program year 2025
  1. Tulsa-Pro Oncology $145,534 100% · 626 recipients

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Urology $82,507 58% · 440 practitioners
  2. Diagnostic Radiology Radiology $35,552 25% · 30 practitioners
  3. Vascular & Interventional Radiology Radiology $12,764 9% · 25 practitioners
  4. Physician Assistant $3,517 2% · 34 practitioners
  5. Anesthesiology $2,133 1% · 5 practitioners

The top 5 of 31 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $44,176 30% · 98 recipients
  2. Florida $15,186 10% · 55 recipients
  3. Texas $14,784 10% · 21 recipients
  4. Arizona $7,813 5% · 18 recipients
  5. Tennessee $5,765 4% · 14 recipients

The top 5 of 43 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2020–2025
  1. Travel and Lodging $179,574 195 payments
  2. Food and Beverage $130,954 1,469 payments
  3. Consulting Fee $19,075 10 payments
  4. Honoraria $8,800 3 payments
  5. Entertainment $280 1 payment
1,678 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record